March 13, 2020 / 12:23 PM / 25 days ago

BRIEF-Athenex Inc's Operational Plans Continue To Remain On Track

March 13 (Reuters) - Athenex Inc:

* ATHENEX INC - OPERATIONAL PLANS CONTINUE TO REMAIN ON TRACK

* ATHENEX - ASSESSMENT IS, NDA SUBMISSION FOR ORAL PACLITAXEL, PRE-LAUNCH PREPARATIONS FOR ORAL PACLITAXEL, TIRBANIBULIN OINTMENT SHOULD NOT BE IMPACTED

* ATHENEX INC - INTERACTIONS WITH U.S. FDA AND OTHER REGULATORY AUTHORITIES CURRENTLY REMAIN ON SCHEDULE

* ATHENEX INC - COMPANY’S INTERACTIONS WITH U.S. FDA AND OTHER REGULATORY AUTHORITIES CURRENTLY REMAIN ON SCHEDULE

* ATHENEX INC - TAIHAO PLANT IS CONTINUING TO PRODUCE API FOR CLINICAL AND REGISTRATION NEEDS

* ATHENEX - CHINA OPERATIONS IN CHONGQING HAVE RESUMED IN FIRST WEEK OF MARCH IN ACCORDANCE WITH RECOMMENDATIONS BY LOCAL AUTHORITIES

* ATHENEX INC - CONSTRUCTION OF NEW API PLANT CONTINUES TO REMAIN ON SCHEDULE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below